470
Views
18
CrossRef citations to date
0
Altmetric
Original Articles

Dermal targeting of Centella asiatica extract using hyaluronic acid surface modified niosomes

, ORCID Icon, , ORCID Icon & ORCID Icon
Pages 197-207 | Received 13 Dec 2018, Accepted 22 Apr 2019, Published online: 27 May 2019

References

  • Abraham, W., and Downing, D.T., 1990. Interaction between corneocytes and stratum corneum lipid liposomes in vitro. Biochimica biophysica acta, 1021 (2), 119–125.
  • Arafa, M.G., and Ayoub, B.M., 2017. DOE Optimization of nano-based carrier of pregabalin as hydrogel: new therapeutic & chemometric approaches for controlled drug delivery systems. Scientific reports, 7, 41503.
  • Arpicco, S., et al., 2013. Hyaluronic acid-coated liposomes for active targeting of gemcitabine. European journal of pharmaceutics and biopharmaceutics : official journal of arbeitsgemeinschaft fur pharmazeutische verfahrenstechnik e.v, 85 (3 Pt A), 373–380.
  • Bayindir, Z.S., and Yuksel, N., 2010. Characterization of niosomes prepared with various nonionic surfactants for paclitaxel oral delivery. Journal of pharmaceutical sciences, 99 (4), 2049–2060.
  • Biswal, S., et al., 2008. Vesicles of non-ionic surfactants (niosomes) and drug delivery potential. International journal of pharmaceutical sciences and nanotechnology, 1, 1–8.
  • Bonifácio, B.V., et al., 2014. Nanotechnology-based drug delivery systems and herbal medicines: a review. International journal of nanomedicine, 9, 1–15.
  • Chen, S., et al., 2015. Degradation of hyaluronic acid derived from tilapia eyeballs by a combinatorial method of microwave, hydrogen peroxide, and ascorbic acid. Polymer degradation and stability, 112, 117–121.
  • Chen, Y., et al., 2009. Study of artemisinin nanocapsules as anticancer drug delivery systems. Nanomedicine : nanotechnology, biology, and medicine, 5 (3), 316–322.
  • Chrai, S.S., Murari, R., and Ahmed, I., 2002. Liposomes (a review). Part two: drug delivery systems. Biopharm, 15, 40–49.
  • Cilurzo, F., et al., 2014. The role of the conformational profile of polysaccharides on skin penetration: the case of hyaluronan and its sulfates. Chemistry and biodiversity, 11, 551–561.
  • Dan, N., 2018. Chapter 1, Vesicle-based drug carriers: liposomes, polymersomes, and niosomes In: A.M. Grumezescu, ed. Design and Development of New Nanocarriers, Norwich, NY: William Andrew Publishing, 1–55.
  • Dechert, T.A., et al., 2006. Hyaluronan in human acute and chronic dermal wounds. Wound repair and regeneration : official publication of the wound healing society [and] the European tissue repair society, 14 (3), 252–258.
  • Essa, E., 2010. Effect of formulation and processing variables on the particle size of sorbitan monopalmitate niosomes. Asian journal of pharmaceutics, 4 (4), 227–233.
  • Franze, S., et al., 2018. Hyaluronan-decorated liposomes as drug delivery systems for cutaneous administration. International journal of pharmaceutics, 535 (1–2), 333–339.
  • Gohil, K.J., Patel, J.A., and Gajjar, A.K., 2010. Pharmacological review on Centella asiatica: a potential herbal cure-all. Indian journal of pharmaceutical sciences, 72 (5), 546–556.
  • Greenwood, R., and Kendall, K., 1999. Electroacoustic studies of moderately concentrated colloidal suspensions. Journal of european ceramic society, 19 (4), 479–488.
  • Hao, Y., et al., 2002. Studies on a high encapsulation of colchicine by a niosome system. International journal of pharmaceutics, 224, 73–80.
  • He, M., et al., 2009. Hyaluronic acid coated poly(butyl cyanoacrylate) nanoparticles as anticancer drug carriers. International journal of pharmaceutics, 373 (1–2), 165–173.
  • James, J.T., and Dubery, I.A., 2009. Pentacyclic triterpenoids from the medicinal herb, Centella asiatica (L.) urban. Molecules, 14 (10), 3922–3941.
  • Juhlin, L., 1997. Hyaluronan in skin. Journal of internal medicine, 242 (1), 61.
  • Junyaprasert, V.B., Teeranachaideekul, V., and Supaperm, T., 2008. Effect of charged and non-ionic membrane additives on physicochemical properties and stability of niosomes. AAPS pharmscitech, 9 (3), 851.
  • Junyaprasert, V.B., et al., 2012. Physicochemical properties and skin permeation of Span 60/Tween 60 niosomes of ellagic acid. International journal of pharmaceutics, 423 (2), 303–311.
  • Khaled, A., Usama, F.A., and Doaa, A.T., 2014. Reducing topical mometasone furoate doses by applying hyaluronic acid as a skin penetration enhancer. GJMR b pharma drug discovery, toxicology and medicine, 14 (5), 13–24.
  • Laurent, T. C., 1970. Structure of hyaluronic acid. In: Balazs EA, ed. Chemistry and the molecular biology of the intracellular matrix. London: Academic Press. 703–732.
  • Li, W., et al., 2016. Hyaluronic acid ion-pairing nanoparticles for targeted tumor therapy. Journal of controlled release : official journal of the controlled release society, 225, 170–182.
  • Liopo, A., et al., 2016. Optical clearing of skin enhanced with hyaluronic acid for increased contrast of optoacoustic imaging. Journal of biomedical optics, 21 (8), 081208.
  • Liu, T., and Guo, R., 2005. Preparation of a highly stable niosome and its hydrotrope solubilization action to drugs. Langmuir, 21 (24), 11034–11039.
  • Lu, G. W., and Gao, P., 2010. Chapter 3, Emulsions and microemulsions for topical and transdermal drug delivery. In: V.S. Kulkarni, ed. Handbook of Non-Invasive Drug Delivery Systems. Boston: William Andrew Publishing, p. 59–94.
  • Manosroi, A., Jantrawut, P., and Manosroi, J., 2008. Anti-inflammatory activity of gel containing novel elastic niosomes entrapped with diclofenac diethylammonium. International journal of pharmaceutics, 360 (1–2), 156–163.
  • Manuskiatti, W., and Maibach, H.I., 1996. Hyaluronic acid and skin: wound healing and aging. International journal of dermatology, 35 (8), 539–544.
  • Meyer, L., and Palmer, J., 1934. The polysaccharide of the vitreous humour. The journal of biological chemistry, 107, 629–634.
  • Mohamed, H.B., et al., 2017. Niosomes: a strategy toward prevention of clinically significant drug incompatibilities. Scientific reports, 7 (1), 6340.
  • Motokawa, K., et al., 2006. Selectively crosslinked hyaluronic acid hydrogels for sustained release formulation of erythropoietin. Journal of biomedical materials research part a, 78 (3), 459–465.
  • Palozza, P., et al., 2006. Solubilization and stabilization of beta-carotene in niosomes: delivery to cultured cells. Chemistry and physics of lipids, 139 (1), 32–42.
  • Park, J.H., et al., 2014. Hyaluronic acid derivative-coated nanohybrid liposomes for cancer imaging and drug delivery. Journal of controlled release : official journal of the controlled release society, 174, 98–108.
  • Preston, B.N., Davies, M., and Ogston, A.G., 1965. The composition and physicochemical properties of hyaluronic acids prepared from ox synovial fluid and from a case of mesothelioma. Biochemical journal, 96 (2), 449–474.
  • RajaNaresh, R.A., et al., 1994. Anti-inflammatory activity of niosome encapsulated diclofenac sodium in arthritic rats. Indian Journal of Pharmacology, 26, 46–48.
  • Ravar, F., et al., 2016. Hyaluronic acid-coated liposomes for targeted delivery of paclitaxel, in-vitro characterization and in-vivo evaluation. Journal of controlled release : official journal of the controlled release society, 10 (229), 10–22.
  • Reddy, B., 2014. Factors affecting in formation of Niosomes. Indo American journal of pharmaceutical research, 4, 2087–2091.
  • Solanki, A.B., Parikh, J.R., and Parikh, R.H., 2010. Evaluation of different compositions of niosomes to optimize aceclofenac transdermal delivery. Asian journal of pharmaceutical sciences, 5, 87–95.
  • Songkro, S., 2009. An overview of skin penetration enhancers: penetration enhancing activity, skin irritation potential and mechanism of action. Songklanakarin journal of science and technology, 31 (3), 299–321.
  • Srikanth, K., et al., 2010. Niosomes: a prominent tool for transdermal drug delivery. Research journal of pharmaceutical biological and chemical sciences, 1, 308–316.
  • Taymouri, S., and Varshosaz, J., 2016. Effect of different types of surfactants on the physical properties and stability of carvedilol nano-niosomes. Advanced biomedical research, 5, 48.
  • Tripodo, G., et al., 2015. Hyaluronic acid and its derivatives in drug delivery and imaging: recent advances and challenges. European journal of pharmaceutics and biopharmaceutics : official journal of arbeitsgemeinschaft fur pharmazeutische verfahrenstechnik e.v, 97 (Pt B), 400–416.
  • Uchegbu, I.F., and Florence, A.T., 1995. Non-ionic surfactant vesicles (niosomes): physical and pharmaceutical chemistry. Advances in colloid and interface science, 58 (1), 1–55.
  • Uchegbu, I.F., and Vyas, S.P., 1998. Non-ionic surfactant based vesicles (niosomes) in drug delivery. International journal of pharmaceutics, 172 (1–2), 33–70.
  • Varga, L., 1955. Studies on hyaluronic acid prepared from the vitreous body. The journal of biological chemistry, 217 (2), 651–658.
  • Wu, J., et al., 2010. Hierarchically [sic] nanostructured mesoporous spheres of calcium silicate hydrate: surfactant-free sonochemical synthesis and drug-delivery system with ultrahigh drug-loading capacity. Advanced materials, 22 (6), 749–753.
  • Zubairu, Y., et al., 2015. Design and development of novel bioadhesive niosomal formulation for the transcorneal delivery of anti-infective agent: in-vitro and ex-vivo investigations. Asian journal of pharmaceutical sciences, 10 (4), 322–330.
  • Zeng, W., et al., 2016. Hyaluronic acid-coated niosomes facilitate tacrolimus ocular delivery: mucoadhesion, precorneal retention, aqueous humor pharmacokinetics, and transcorneal permeability. Colloids and Surfaces. B, Biointerfaces, 141, 28–35.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.